Abstract:
Alterations to the ERG gene are some of the most prominent genomic changes associated with many cancers including prostate cancer. Such cancer specific alterations result in the overexpression of wild type ERG protein or an altered ERG protein. The present invention provides selective inhibitors of wild type or an altered ERG protein expression. The ERG inhibitors of the invention, therefore, are therapeutic agents for treating ERG positive cancers.
Abstract:
Dyes of the formula ##STR1## where the ring A may be benzofused and R.sup.1 -R.sup.6 have the meaning defined in the specification, with the proviso that at least one quaternizable or quaternary group is present in the molecule; use of said dyes for dyeing or printing polymeric material, and novel amides of J-acid.
Abstract:
Disperse dyes of the general formula I ##STR1## wherein D signifies a diazo component which is usual with disperse dyes, K signifies an aromatic radical of formula ##STR2## Y signifies ##STR3## and the other symbols have the meanings as defined in claim 1, are useful for dyeing or printing hydrophobic, fully or half-synthetic organic fiber materials.
Abstract:
The disperse dyes of formula I ##STR1## wherein the symbols D, K, R.sub.3-5, R.sub.10, m, z, n and Y possess the significances given in claim 1, are eminently suitable for dyeing or printing hydrophobic, fully or semi-synthetic, organic fiber materials.
Abstract:
A photographic light-sensitive sheet for the color diffusion transfer process which comprises a support having thereon at least one light-sensitive silver halide emulsion layer having associated therewith a compound represented by the following general formula (I): ##STR1## wherein X.sup.1 represents --J--NR.sup.2 -- or --NR.sup.2 --J-- wherein R.sup.2 represents a hydrogen atom or an alkyl group, and J represents --SO.sub.2 -- or --CO--; R.sup.1 represents an alkyl group; X.sup.2 represents --R.sup.3 --L).sub.k (R.sup.4).sub.e -- wherein R.sup.3 and R.sup.4, which may be the same or different, each represents an alkylene group, a substituted alkylene group, a phenylene group or a substituted phenylene group, L represents --O--, --CO--, --SO.sub.2 NH--, --CONH--, --NHSO.sub.2 --, --NHCO--, --SO.sub.2 -- or --SO--, k represents 0 or 1, and e represents 1 when k is 1, or 1 or 0 when k is 0, provided that when X.sup.2 bonds to X.sup.1, X.sup.1 bonds to R.sup.3 ; i and j each represents 0 or 1; and Y represents a moiety which provides, as a result of development processing under alkaline conditions, an azo dye compound having a different diffusibility from that of the azo dye image-forming compound represented by the formula (I).
Abstract:
A 2-alkoxyalkoxy-5-aminobenzenesulfonic acid represented by the following general formula (I): ##STR1## wherein R.sup.1 represents an alkylene group having 2 or more carbon atoms; and R.sup.2 represents an alkyl group. The compound can be used as an intermediate in the production of a dye releasing redox compound.
Abstract:
Alterations to the ERG gene are some of the most prominent genomic changes associated with many cancers including prostate cancer. Such cancer specific alterations result in the overexpression of wild type ERG protein or an altered ERG protein. The present invention provides selective inhibitors of wild type or an altered ERG protein expression. The ERG inhibitors of the invention, therefore, are therapeutic agents for treating ERG positive cancers.
Abstract:
A color-developing agent of the formula (1-1): 1 wherein X represents a hydrogen atom or a substituent, and Z represents a carbamoyl, acyl, alkoxycarbonyl, or aryloxycarbonyl group. An azo dye of the formula (2-1): 2 wherein R1 represents a hydrogen atom or a substituent, and A represents a group of atoms necessary to form the azo dye by the compound of formula (2-1). A silver halide photographic light-sensitive material containing any of the color-developing agent and the azo dye in at least one photographic constitutional layer.
Abstract:
There are described dyes of the formula ##STR1## where the ring A may be benzofused, R.sup.1 is substituted or unsubstituted C.sub.1 -C.sub.13 -alkyl, substituted or unsubstituted phenyl, C.sub.1 -C.sub.8 -alkanoyl, substituted or unsubstituted benzoyl, substituted C.sub.2 -C.sub.4 -alkanoyl, or substituted diaminotriazinyl,R.sup.2 is hydrogen or C.sub.1 -C.sub.4 -alkyl or R.sup.1 and R.sup.2 together with the nitrogen atom joining them together are a heterocyclic radical,R.sup.3 and R.sup.4 are each substituted or unsubstituted C.sub.1 -C.sub.13 -alkyl, substituted or unsubstituted C.sub.5 -C.sub.7 -cycloalkyl or substituted or unsubstituted piperidinyl and R.sup.3 may also be hydrogen,R.sup.5 is hydrogen, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy, C.sub.2 -C.sub.5 -alkanoylamino, halogen, nitro, cyano, substituted or unsubstituted phenylazo, C.sub.2 -C.sub.4 -alkanoylamino substituted by a quaternizable or quaternary group, or C.sub.2 -C.sub.4 -alkoxy, C.sub.2 -C.sub.4 -alkoxycarbonyl or C.sub.2 -C.sub.4 -alkoxycarbamoyl which are each substituted by a quaternizable or quaternary group, andR.sup.6 is hydrogen, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy, halogen, nitro or cyano,with the proviso that at least one quaternizable or quaternary group is present in the molecule, the use thereof for dyeing or printing polymeric material, and novel amides of J-acid.